Carbon Sciences develops new process to extend enzyme life, reduce biocatalytic costs

In California, Carbon Sciences announced that it has developed a process that increases the functional life of key enzymes used in the company’s biocatalytic CO2 to fuel process.

According to CTO Naveed Aslam, the company has encapsulated the enzymes in a protective shell that increases the activity and enzyme functional lifespan.  The commercial viability of any biocatalytic process is dependent on the number of cycles the enzymes can perform – Total Turnover Number (TTN) – before replacement. Carbon Science’s process results in a higher TTN, more products produced with the same fixed cost of enzymes, and a lower cost per unit of product.

Carbon Sciences Inc. is developing a technology to recycle carbon dioxide (CO2) emissions into gasoline, diesel fuel, jet fuel and other fuels.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Carbon Sciences files for patents on CO2-to-fuel biocatalytic conversion technology

In California, Carbon Sciences,  developer of a technology to transform carbon dioxide (CO2) emissions into gasoline and other fuels, announced the filing of the first in a series of patent applicati...

Genencor launches next-gen enzyme package; will reduce cost of cellulosic ethanol production

In Denmark, Genencor announced the launch of its next-generation cellulosic ethanol enzyme, which it called Accellerase 1500. The company said that the new generation of enzymes would reduce the co...

Shell announces six academic research partnerships for biofuels

In the Netherlands, Royal Dutch Shell announced six research partnerships with academic institutions, ranging from two to five years in duration, to pursue biofuels development. The agreements were...

Japanese researcher develops low-cost cellulosic ethanol catalyst; reduces conversion costs by 30 percent

In Japan, a professor at Tokyo Institute of Technology announced a process to reduce the cost of cellulosic ethanol conversion from rice straw and other non-food feedstocks by more than 30 percent. Th...

Gevo secures $17 million from Burrill & Co and Malaysian Life Sciences in third round

In California. Gevo announced that Burill & Co and Malaysian Life Sciences Capital Fund have joined a $17 million third round of financing that closed this week, joining Vinod Khosla's Khosla Vent...

Dyadic says it has received “generally recognized as safe” notice from FDA for enzyme platform

In Florida, Dyadic International said it had received a generally recognized as safe ("GRAS") , notice from the FDA for cellulase enzyme preparation derived from a genetically modified strain of the c...